WHO launches the Global TB Report 2025
WHO launches the Global TB Report 2025 The World Health Organization (WHO) has released the Global Tuberculosis (TB) Report 2025. This report offers a thorough and current evaluation of the TB epidemic, as well as progress made in preventing, diagnosing, and treating the disease at global, regional, and country levels. This is done in the […]
Announcement Awardees | TBVI Awards 2026
Announcement Awardees | TBVI Awards 2026 The TBVI Award aims to encourage promising scientists by recognising their outstanding contributions to tuberculosis (TB) vaccine research and development. It offers them a platform to showcase their work at the TBVI symposium, taking place on January 27-28, 2026, in the picturesque Les Diablerets, Switzerland. This annual meeting is […]
Phase 1b/2a clinical trial in adults of novel TB vaccine candidate MTBVAC shows promising results
MTBVAC caused similar or stronger immune responses compared to the Bacille Calmette-Guérin (BCG) vaccine. NEW YORK, USA, PORRIÑO, SPAIN, CAPE TOWN, SOUTH AFRICA – April 22, 2025 – IAVI, Biofabri, the University of Zaragoza (UNIZAR), and the South African Tuberculosis Vaccine Initiative (SATVI) are pleased to announce today promising results from the IAVI-sponsored A-050 […]
Announcement TBVI Awards 2026
Would you like to present your work at the TBVI Annual Symposium? To encourage promising scientists and recognise outstanding contributions to TB vaccine research and development, TBVI presents the TBVI Awards. Promising scientists are given the opportunity to give a 15-minute presentation about their work during the annual TBVI symposium where researchers, policymakers, and funders […]
Third call for applications to assess efficacy of Mycobacterium tuberculosis vaccine candidates
Diversifying the vaccine development pipeline has been recognized as a priority in the Global TB Vaccine R&D Roadmap. The TBVAC-HORIZON consortium has successfully secured funding for a four-year project that aims to fill the early stages of the development pipeline while ensuring a diverse portfolio of vaccine candidates (TBVAC-HORIZON – TBVI). One of the key […]
TBVI Awardees 2025
With the TBVI Award, TBVI encourages promising scientists and rewards their remarkable contributions to tuberculosis (TB) vaccine research and development, by offering them the opportunity to present their work at the TBVI symposium that takes place 28-29 January 2025 in Les Diablerets. This annual meeting is dedicated to the exchange of knowledge and the fostering […]
Announcement TBVI Award 2025
Would you like to present your work at the TBVI Annual Symposium? To encourage promising scientists and recognise outstanding contributions to TB vaccine research and development, TBVI presents the TBVI Awards. Promising scientists are given the opportunity to give a 15-minute presentation (incl. discussion) about their work during the annual TBVI symposium where researchers, policy […]
TBVI and EVI team up with VAC4EU
TBVI and EVI announce a new partnership with Vaccine Monitoring Collaboration for Europe (VAC4EU). VAC4EU is a pan-European research network for post-authorisation vaccine safety and benefit monitoring, specialised in the collaborative generation of real-world evidence on coverage, safety, and efficacy of vaccines in Europe. TBVI and EVI are both European non-profit Product Development Partnerships (PDPs) […]
Biofabri and TBVI sign a contract with the European Health and Digital Executive Agency to accelerate the final development of the new TB vaccine MTBVAC
Biofabri and TBVI have signed a contract with the European Health and Digital Executive Agency (HaDEA) under the EU4Health Programme to accelerate the final development of the MTBVAC vaccine. MTBVAC is a highly promising vaccine candidate that has the potential to be used as an alternative to BCG vaccination in infants and for prevention of […]
Vacancy at TBVI for a Scientific Project Manager
TBVI has an exciting career opportunity for a motivated individual to join the organisation as Scientific Project Manager (full-time or part-time). You will join a small, enthusiastic team, dedicated to TBVI’s goals to relieve the burden of TB and eliminate tuberculosis around the world. Applications with the requested information should be submitted in English and […]